{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:12:05Z","timestamp":1791994325888,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s13555-015-0070-9","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T06:35:46Z","timestamp":1422858946000},"page":"19-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Primary Care Review of Actinic Keratosis and Its Therapeutic Options: A Global Perspective"],"prefix":"10.1007","volume":"5","author":[{"given":"Praven","family":"Chetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"70_CR1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/CIA.S31930","volume":"8","author":"EE Uhlenhake","year":"2013","unstructured":"Uhlenhake EE. Optimal treatment of actinic keratoses. Clin Interv Aging. 2013;8:29\u201335.","journal-title":"Clin Interv Aging"},{"key":"70_CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0365-05962012000300012","volume":"87","author":"JV Schmitt","year":"2012","unstructured":"Schmitt JV, Miot HA. Actinic keratosis: a clinical and epidemiological revision. An Bras Dermatol. 2012;87:425\u201334.","journal-title":"An Bras Dermatol."},{"key":"70_CR3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/bjc.1996.535","volume":"74","author":"I Harvey","year":"1996","unstructured":"Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farrell M. Non-melanoma skin cancer and solar keratoses II analytical results of the South Wales Skin Cancer Study. Br J Cancer. 1996;74:1308\u201312.","journal-title":"Br J Cancer"},{"key":"70_CR4","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1067\/mjd.2000.103343","volume":"42","author":"RL Moy","year":"2000","unstructured":"Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:S8\u201310.","journal-title":"J Am Acad Dermatol"},{"key":"70_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2000.103339","volume":"42","author":"RG Glogau","year":"2000","unstructured":"Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42:23\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"70_CR6","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jaad.2012.10.001","volume":"68","author":"DS Rigel","year":"2013","unstructured":"Rigel DS. Stein Gold LF. The importance of early diagnosis and treatment of actinic keratosis. J Am Acad Dermatol. 2013;68(Suppl 1):S20\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"70_CR7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jaad.2012.09.052","volume":"68","author":"T Rosen","year":"2013","unstructured":"Rosen T, Lebwohl MG. Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol. 2013;68:S2\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"70_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1751-1097.1982.tb03830.x","volume":"35","author":"DS Berger","year":"1982","unstructured":"Berger DS, Urbach F. A climatology of sunburning ultraviolet radiation. Photochem Photobiol. 1982;35:187\u201392.","journal-title":"Photochem Photobiol"},{"key":"70_CR9","first-page":"20","volume":"5","author":"MS Nestor","year":"2012","unstructured":"Nestor MS, Zarraga MB. The incidence of nonmelanoma skin cancers and actinic keratoses in South Florida. J Clin Aesthet Dermatol. 2012;5:20\u20134.","journal-title":"J Clin Aesthet Dermatol."},{"key":"70_CR10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.5694\/j.1326-5377.1989.tb139626.x","volume":"151","author":"R Marks","year":"1989","unstructured":"Marks R. Freckles, moles, melanoma and the ozone layer: a tale of the relationship between humans and their environment. Med J Aust. 1989;151:611\u20133.","journal-title":"Med J Aust"},{"key":"70_CR11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2006.07692.x","volume":"156","author":"D Berker de","year":"2007","unstructured":"de Berker D, McGregor JM, Hughes BR. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007;156:222\u201330.","journal-title":"Br J Dermatol"},{"key":"70_CR12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00105-003-0543-0","volume":"54","author":"P Babilas","year":"2003","unstructured":"Babilas P, Landthaler M, Szeimies RM. Actinic keratoses. Hautarzt. 2003;54:551\u201360.","journal-title":"Hautarzt"},{"key":"70_CR13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mjd.2000.103342","volume":"42","author":"SJ Salasche","year":"2000","unstructured":"Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"70_CR14","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1046\/j.1365-2133.2000.03541.x","volume":"142","author":"AA Memon","year":"2000","unstructured":"Memon AA, Tomenson JA, Bothwell J, Friedmann PS. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol. 2000;142:1154\u20139.","journal-title":"Br J Dermatol"},{"key":"70_CR15","first-page":"CD004415","volume":"12","author":"AK Gupta","year":"2012","unstructured":"Gupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;12:CD004415.","journal-title":"Cochrane Database Syst Rev."},{"key":"70_CR16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","volume":"68","author":"PS Karia","year":"2013","unstructured":"Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol. 2013;68:957\u201366.","journal-title":"J Am Acad Dermatol"},{"key":"70_CR17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1468-3083.2004.00993.x","volume":"18","author":"RM MacKie","year":"2004","unstructured":"MacKie RM. Awareness, knowledge and attitudes to basal cell carcinoma and actinic keratoses among the general public within Europe. J Eur Acad Dermatol Venereol. 2004;18:552\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"70_CR18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-4632.2004.02124.x","volume":"43","author":"AC Halpern","year":"2004","unstructured":"Halpern AC, Hanson LJ. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians. Int J Dermatol. 2004;43:638\u201342.","journal-title":"Int J Dermatol"},{"key":"70_CR19","unstructured":"The Lewin Group Inc. for The Society for Investigative Dermatology and The American Academy of Dermatology Association. The burden of skin diseases. Available from: http:\/\/www.lewin.com\/~\/media\/Lewin\/Site_Sections\/Publications\/april2005skindisease.pdf . Last accessed April 22, 2013."},{"issue":"Suppl 1","key":"70_CR20","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jaad.2012.09.051","volume":"68","author":"RI Ceilley","year":"2013","unstructured":"Ceilley RI, Jorizzo JL. Current issues in the management of actinic keratosis. J Am Acad Dermatol. 2013;68(Suppl 1):S28\u201338.","journal-title":"J Am Acad Dermatol"},{"key":"70_CR21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/archderm.1995.01690140054008","volume":"131","author":"MF Naylor","year":"1995","unstructured":"Naylor MF, Boyd A, Smith DW, Cameron GS, Hubbard D, Neldner KH. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995;131:170\u20135.","journal-title":"Arch Dermatol"},{"key":"70_CR22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJM199310143291602","volume":"329","author":"SC Thompson","year":"1993","unstructured":"Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329:1147\u201351.","journal-title":"N Engl J Med"},{"key":"70_CR23","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1158\/1055-9965.EPI-06-0352","volume":"15","author":"JC Pols van der","year":"2006","unstructured":"van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomark Prev. 2006;15:2546\u20138.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"70_CR24","first-page":"651","volume":"18","author":"E Stockfleth","year":"2008","unstructured":"Stockfleth E, Ferrandiz C, Grob JJ, Leigh I, Pehamberger H, Kerl H. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol. 2008;18:651\u20139.","journal-title":"Eur J Dermatol."},{"key":"70_CR25","unstructured":"Reeve T. Cancer Council Australia 2008 Clinical Practice Guide Basal cell carcinoma, squamous cell carcinoma (and related lesions): a guide to clinical management in Australia. Available from: http:\/\/www.cancer.org.au\/content\/pdf\/HealthProfessionals\/ClinicalGuidelines\/Basal_cell_carcinoma_Squamous_cell_carcinoma_Guide_Nov_2008-Final_with_Corrigendums.pdf . Last accessed Nov 8, 2013."},{"key":"70_CR26","unstructured":"Schumack PS. Australian Prescriber: non-surgical treatments for skin cancer. Available from: http:\/\/www.australianprescriber.com\/magazine\/34\/1\/6\/7 . Last accessed Nov 8, 2013."},{"key":"70_CR27","first-page":"539","volume":"36","author":"A Chia","year":"2007","unstructured":"Chia A, Moreno G, Lim A, Shumack S. Actinic keratoses. Aust Fam Physician. 2007;36:539\u201343.","journal-title":"Aust Fam Physician"},{"key":"70_CR28","unstructured":"Sterry W. European Dermatology Forum Guideline on Actinic Keratosis. Available from: http:\/\/www.ensas.ee\/docs\/management_of_actinic_keratoses.pdf . Last accessed Nov 8, 2013."},{"key":"70_CR29","unstructured":"Pharmaderm. Solaraze gel. Prescribing information. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/021005s013lbl.pdf . Last accessed April 10, 2014."},{"key":"70_CR30","first-page":"197","volume":"36","author":"D Jenerowicz","year":"2013","unstructured":"Jenerowicz D, Jabubowicz O, Polanska A, Sadowska A, Danczak-Pazdrowska A, Zaba R. Photosensitivity to selected topical nonsteroidal anti-inflammatory drugs preparations\u2014a review of literature data and author\u2019s own experience. Cent Eur J Immunol. 2013;36:197\u2013203.","journal-title":"Cent Eur J Immunol."},{"key":"70_CR31","unstructured":"Electronic Medicines Consortium (eMC). Solaraze SmPC. Available from: http:\/\/www.medicines.org.uk\/emc\/medicine\/21229\/SPC . Last accessed April 10, 2014."},{"key":"70_CR32","unstructured":"3M Health Care Limited. Aldara (Imiquimod): Highlights of prescribing information. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/020723s020lbl.pdf . Last accessed June 4, 2014."},{"issue":"Suppl 2","key":"70_CR33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2133.2007.08272.x","volume":"157","author":"E Stockfleth","year":"2007","unstructured":"Stockfleth E, Sterry W, Carey-Yard M, Bichel J. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. Br J Dermatol. 2007;157(Suppl 2):41\u20136.","journal-title":"Br J Dermatol"},{"key":"70_CR34","first-page":"1101","volume":"9","author":"JL Jorizzo","year":"2010","unstructured":"Jorizzo JL, Markowitz O, Lebwohl MG, et al. A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses. J Drugs Dermatol. 2010;9:1101\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"1 Suppl 1","key":"70_CR35","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jaad.2012.09.050","volume":"68","author":"G Martin","year":"2013","unstructured":"Martin G, Swanson N. Clinical findings using ingenol mebutate gel to treat actinic keratoses. J Am Acad Dermatol. 2013;68(1 Suppl 1):S39\u201348.","journal-title":"J Am Acad Dermatol"},{"key":"70_CR36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","volume":"366","author":"M Lebwohl","year":"2012","unstructured":"Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366:1010\u20139.","journal-title":"N Engl J Med"},{"key":"70_CR37","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamadermatol.2013.2766","volume":"149","author":"M Lebwohl","year":"2013","unstructured":"Lebwohl M, Shumack S, Gold LS, Melgaard A, Larsson T, Tyring SK. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses. JAMA Dermatol. 2013;149:666\u201370.","journal-title":"JAMA Dermatol."},{"key":"70_CR38","first-page":"35","volume":"7","author":"JS Dosik","year":"2014","unstructured":"Dosik JS, Damstra M, Udell C, Welburn P. Evaluation of the skin sensitization, photoirritation, and photoallergic potential of ingenol mebutate gel in healthy volunteers. J Clin Aesthet Dermatol. 2014;7:35\u201342.","journal-title":"J Clin Aesthet Dermatol."},{"key":"70_CR39","first-page":"154","volume":"13","author":"B Berman","year":"2014","unstructured":"Berman B, Goldenberg G, Hanke W, et al. Efficacy and safety of ingenol mebutate 0.015% gel 3\u00a0weeks after cryosurgery of actinic keratosis: 11-week results. J Drugs Dermatol. 2014;13:154\u201360.","journal-title":"J Drugs Dermatol"},{"key":"70_CR40","first-page":"741","volume":"13","author":"B Berman","year":"2014","unstructured":"Berman B, Goldenberg G, Hanke CW, et al. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results. J Drugs Dermatol. 2014;13:741\u20137.","journal-title":"J Drugs Dermatol"},{"key":"70_CR41","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-4632.2012.05776.x","volume":"52","author":"JE Wolf Jr","year":"2013","unstructured":"Wolf JE Jr, Rigel DS. Understanding efficacy end-points in studies of field-directed therapy for actinic keratosis. Int J Dermatol. 2013;52:1063\u201370.","journal-title":"Int J Dermatol"},{"key":"70_CR42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/her\/cyp060","volume":"25","author":"R Garside","year":"2010","unstructured":"Garside R, Pearson M, Moxham T. What influences the uptake of information to prevent skin cancer? A systematic review and synthesis of qualitative research. Health Educ Res. 2010;25:162\u201382.","journal-title":"Health Educ Res"},{"key":"70_CR43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1440-0960.2011.00785.x","volume":"52","author":"DT Tran","year":"2011","unstructured":"Tran DT, Salmon R. Field treatment of facial and scalp actinic keratoses with photodynamic therapy: survey of patient perceptions of treatment satisfaction and outcomes. Australas J Dermatol. 2011;52:195\u2013201.","journal-title":"Australas J Dermatol"},{"key":"70_CR44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-4632.2004.02477.x","volume":"45","author":"CL Streeton","year":"2006","unstructured":"Streeton CL, Gospodarevskaya E, Harris AH. How are solar keratoses treated by general practitioners in Australia? Int J Dermatol. 2006;45:272\u20136.","journal-title":"Int J Dermatol"},{"key":"70_CR45","unstructured":"Primary Care Dermatology Society. Actinic keratosis (syn. solar keratosis). Available from: http:\/\/www.pcds.org.uk\/clinical-guidance\/actinic-keratosis-syn.-solar-keratosis . Last accessed April 17, 2014."},{"key":"70_CR46","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdv.12031","volume":"27","author":"CA Morton","year":"2013","unstructured":"Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications\u2014actinic keratoses, Bowen\u2019s disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27:536\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"70_CR47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1468-3083.2011.04386.x","volume":"26","author":"SR Wiegell","year":"2012","unstructured":"Wiegell SR, Wulf HC, Szeimies RM, et al. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol. 2012;26:673\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"70_CR48","unstructured":"National Institute for Health and Care Excellence (NICE). Actinic keratosis ingenol mebutate gel. Available from: http:\/\/www.nice.org.uk\/advice\/esnm14 . Last accessed Jan 20, 2014."},{"key":"70_CR49","unstructured":"Scottish Medicines Consortium. Briefing note: ingenol mebutate gel (Picato). Available from: http:\/\/www.scottishmedicines.org.uk\/SMC_Advice\/Advice\/851_13_ingenol_mebutate_gel_Picato\/Briefing_note_ingenol_mebutate_gel_Picato . Last accessed April 11, 2014."},{"key":"70_CR50","first-page":"44","volume":"153","author":"BP AmirthaVani","year":"2005","unstructured":"AmirthaVani BP, Charles-Holmes R, Humphreys F, Bedlow AJ, Gee BC, Benjamin M. Evaluation of the dermatology outpatient service: a general practitioners\u2019 questionnaire survey about the quality of outpatient consultations. Br J Dermatol. 2005;153:44\u20135.","journal-title":"Br J Dermatol."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-015-0070-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T14:45:54Z","timestamp":1598712354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13555-015-0070-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1007\/s13555-015-0070-9","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}